Falcon Real World Evidence Registry
ConditionCancer
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age50-80
SponsorExact Sciences Corporation
About this trial
This is a multi-site registry of patients receiving the Exact Sciences Multicancer Early Detection (MCED) test.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Participant age at time of consent is between 50 and 80 years
Agree to receive the Exact Sciences MCED test and follow-up imaging
Willing and able to provide informed consent
Access to a suitable technology and willing to complete surveys electronically
Disqualifiers
Any invasive tumor (excluding non-melanoma skin cancers) or hematological malignancy in the previous three years or current suspicion of cancer and/or in active treatment (e.g., chemotherapy, radiation therapy, immunotherapy, and/or surgery
Trial population
Cohort will consist of particpants who have scheduled appointments with their primary health care provider at the participating clinics.
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Exact Sciences Multicancer Early Detection (MCED) Test
DeviceExact Sciences MCED test, is a qualitative in vitro diagnostic (IVD) for the detection of alterations in circulating tumor DNA and tumor-associated protein levels, which are commonly associated with cancer. It is performed on plasma derived from peripheral blood specimens.
Treatment groups
25,000 Participants
are divided into 1 treatment groupGroup A: Multicancer Early Detection (MCED) cohort1 intervention
Trial outcomes
Primary outcomes
1
Vital status
Particpant is alive or deceased
Time frame
Up to 5 years2
Cancer status
Presence or absence of cancer
Time frame
Up to 5 yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov